Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
March 08, 2017

Clinical Trials in Immunotherapy

Precision Medicine World Conference (PMWC) 2017 Podium Presentation
Undeniably, cancer immunotherapy is one of the most promising areas in cancer research. New clinical trial approaches are under way to advance immune therapies for cancer. In this presentation, industry and medical representatives discuss their novel and innovative immunotherapy programs which have the goal to expedite treatment of cancer. 

View full presentation here.

  • Patrice Hugo, CSO, Q2 Solutions
  • Jonathan Cheng, Section Head/PDT Lead SCCHN, GCD Oncology, Merck
  • Samir Khleif, Director of GRU Cancer Center, Augusta University
  • Jim Novotny, Group Director, Pharmacodiagnostics, Bristol-Myers Squib